DeltaQuest Foundation, Inc., 31 Mitchell Road, Concord, MA, 01742, USA,
Qual Life Res. 2014 Feb;23(1):9-19. doi: 10.1007/s11136-013-0471-0. Epub 2013 Jul 13.
This study seeks to estimate clinically significant change in quality of life (QOL) appraisal by comparing changes in appraisal over 6 months of follow-up in people with multiple sclerosis who experienced no change in symptoms versus those with worsening symptoms. This estimation is important for enabling valid interpretation of longitudinal change, both in terms of ensuring the comparison of scores and for response shift estimation.
This is a secondary analysis of longitudinal data (N = 859) of participants in the North American Research Committee on Multiple Sclerosis registry. Patient groupings were characterized on the basis of self-reported symptom change over 1 year of follow-up and compared in terms of their responses to the QOL Appraisal Profile. Bonferroni adjustments reduced the type I error rate, and interpretation was restricted to those comparisons with small or larger effect sizes using Cohen's criteria.
The Symptoms Unchanged group evidenced more change in Frame of Reference goal delineation themes and Combinatory Algorithm, whereas the Symptoms Worse group evidenced more change in Sampling of Experience and Standards of Comparison items. The group differences were, however, not large or statistically significant in most cases, likely due to being under-powered to detect interaction effects.
Many aspects of appraisal are relatively constant in the context of unchanging and changing symptom experience, but symptom changes led patients to make substantial shifts in what experiences they sample when thinking about their health-related QOL. These underlying cognitive processes may help people to maintain homeostasis in their perceived QOL.
本研究旨在通过比较多发性硬化症患者在 6 个月随访期间症状无变化组和症状恶化组的评估变化,来估计生活质量(QOL)评估的临床显著变化。这种估计对于确保分数的比较和反应转移估计的有效性解释都很重要。
这是对北美多发性硬化症研究委员会登记处的纵向数据(N=859)的二次分析。根据患者在 1 年随访期间的自我报告症状变化对其进行分组,并根据他们对 QOL 评估概况的反应进行比较。Bonferroni 调整降低了Ⅰ型错误率,解释仅限于那些使用 Cohen 标准具有小或大效应量的比较。
在参考框架目标划定主题和组合算法方面,症状无变化组表现出更多的变化,而在体验采样和比较标准项目方面,症状恶化组表现出更多的变化。然而,在大多数情况下,组间差异并不显著或不具有统计学意义,这可能是由于缺乏检测交互效应的能力。
在症状不变和变化的情况下,评估的许多方面相对稳定,但症状变化导致患者在思考与健康相关的 QOL 时对体验进行实质性的采样。这些潜在的认知过程可能有助于人们在感知的 QOL 中保持体内平衡。